FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

Fallah, Jaleh, Agrawal, Sundeep, Gittleman, Haley · Clinical Cancer Research · 2023